Literature DB >> 6933487

Isoprotein specificity in the hepatic uptake of apolipoprotein E and the pathogenesis of familial dysbetalipoproteinemia.

R J Havel, Y Chao, E E Windler, L Kotite, L S Guo.   

Abstract

The uptake and catabolism of lamellar complexes of rat 125I-labeled apolipoprotein (apo) E with egg lecithin were increased severalfold in perfused livers of rats given large amounts of 17 alpha-ethynylestradiol for 5 days. Estrogen-stimulated uptake of lamellar complexes of human apo E that contained all of the major normally occurring "isoforms" of the protein (apo E-1, E-2, E-3, and E-4) was comparable to that of rat apo E. By contrast, uptake of complexes containing apo E from individuals with familial dysbetalipoproteinemia (dys beta LP; characterized by a lack of apo E-3 and E-4) was stimualted to a much smaller extent. With complexes containing individual isoforms of human apo E, it was shown that estrogen-stimulated hepatic uptake was largely confined to apo E-3 and E-4; uptake of apo E-2 from normolipoproteinemic or dys beta LP individuals, or of apo E-1 from the latter, was stimulated little or not at all. When considered in the light of available information about the hepatic uptake of lipoproteins and the metabolic defect in familial dys beta LP, these results are consistent with the following hypothesis: (i) apo E comprises an essential component of the site for normal recognition of remnants of triglyceride-rich lipoproteins by a specific hepatic receptor; (ii) accumulation of remnant lipoproteins in familial dys beta LP is caused by lack of apo E-3 and E-4, which are the forms of this protein that are primarily recognized by the receptor; and (iii) the normal conversion of remnants of very low density lipoproteins to low density lipoproteins is mediated by the hepatic remnant receptor.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6933487      PMCID: PMC349832          DOI: 10.1073/pnas.77.7.4349

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Isoelectric heterogeneity of the cofactor protein for lipoprotein lipase in human blood plasma.

Authors:  R J Havel; L Kotite; J P Kane
Journal:  Biochem Med       Date:  1979-02

2.  Increased binding of low density lipoprotein to liver membranes from rats treated with 17 alpha-ethinyl estradiol.

Authors:  P T Kovanen; M S Brown; J L Goldstein
Journal:  J Biol Chem       Date:  1979-11-25       Impact factor: 5.157

3.  Effects of estrogen therapy on apolipoprotein E in type II hyperlipoproteinemia.

Authors:  J M Falko; G Schonfeld; J L Witztum; J Kolar; S W Weidman
Journal:  Metabolism       Date:  1979-11       Impact factor: 8.694

4.  Characterization of the sinusoidal transport process responsible for uptake of chylomicrons by the liver.

Authors:  B C Sherrill; J M Dietschy
Journal:  J Biol Chem       Date:  1978-03-25       Impact factor: 5.157

5.  Rapid hepatic clearance of the canine lipoproteins containing only the E apoprotein by a high affinity receptor. Identity with the chylomicron remnant transport process.

Authors:  B C Sherrill; T L Innerarity; R W Mahley
Journal:  J Biol Chem       Date:  1980-03-10       Impact factor: 5.157

6.  Hepatic catabolism of rat and human lipoproteins in rats treated with 17 alpha-ethinyl estradiol.

Authors:  Y S Chao; E E Windler; G C Chen; R J Havel
Journal:  J Biol Chem       Date:  1979-11-25       Impact factor: 5.157

7.  Characterization of subfractions of triglyceride-rich lipoproteins separated by gel chromatography from blood plasma of normolipemic and hyperlipemic humans.

Authors:  T Sata; R J Havel; A L Jones
Journal:  J Lipid Res       Date:  1972-11       Impact factor: 5.922

8.  Characterization of human very low density lipoproteins containing two electrophoretic populations: double pre-beta lipoproteinemia and primary dysbetalipoproteinemia.

Authors:  A Pagnan; R J Havel; J P Kane; L Kotite
Journal:  J Lipid Res       Date:  1977-09       Impact factor: 5.922

9.  Radioimmunoassay of arginine-rich apolipoprotein of rat serum.

Authors:  M Fainaru; R J Havel; K Imaizumi
Journal:  Biochim Biophys Acta       Date:  1977-01-25

10.  Radioimmunoassay of apolipoprotein A-I of rat serum.

Authors:  M Fainaru; R J Havel; T E Felker
Journal:  Biochim Biophys Acta       Date:  1976-09-28
View more
  34 in total

1.  Postprandial plasma retinyl ester response is greater in older subjects compared with younger subjects. Evidence for delayed plasma clearance of intestinal lipoproteins.

Authors:  S D Krasinski; J S Cohn; E J Schaefer; R M Russell
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

2.  Mouse macrophages synthesize and secrete a protein resembling apolipoprotein E.

Authors:  S K Basu; M S Brown; Y K Ho; R J Havel; J L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

3.  Radioimmunoassay of human arginine-rich apolipoprotein, apoprotein E. Concentration in blood plasma and lipoproteins as affected by apoprotein E-3 deficiency.

Authors:  R J Havel; L Kotite; J L Vigne; J P Kane; P Tun; N Phillips; G C Chen
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

4.  Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in patients with familial dysbetalipoproteinemia.

Authors:  A F Stalenhoef; M J Malloy; J P Kane; R J Havel
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

5.  Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice.

Authors:  B J van Vlijmen; A M van den Maagdenberg; M J Gijbels; H van der Boom; H HogenEsch; R R Frants; M H Hofker; L M Havekes
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

6.  Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil.

Authors:  M S Weintraub; S Eisenberg; J L Breslow
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

7.  Variable expression of familial dysbetalipoproteinemia in apolipoprotein E*2 (Lys146-->Gln) Allele carriers.

Authors:  P de Knijff; A M van den Maagdenberg; D I Boomsma; A F Stalenhoef; A H Smelt; J J Kastelein; A D Marais; R R Frants; L M Havekes
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

8.  Increased prevalence of apolipoprotein E4 in type V hyperlipoproteinemia.

Authors:  G Ghiselli; E J Schaefer; L A Zech; R E Gregg; H B Brewer
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

9.  Hepatic uptake of chylomicron remnants in WHHL rabbits: a mechanism genetically distinct from the low density lipoprotein receptor.

Authors:  T Kita; J L Goldstein; M S Brown; Y Watanabe; C A Hornick; R J Havel
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

10.  Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects.

Authors:  S C Rall; K H Weisgraber; T L Innerarity; R W Mahley
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.